UM researchers have developed a deep learning model to predict compound protein interactions. GraphBAN is an inductive ...

Northeastern University researchers resurrected an extinct plant gene, turning back the evolutionary clock to pave a path forward for the development and discovery of new drugs.

PRISM BioLab, Co. Ltd. ("PRISM BioLab"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced ...

Recuresion Pharma (RXRX) stock and other AI-driven biotechs surge as FDA embraces computational models over animal testing ...

A new company has entered the drug discovery space with what it calls a “chemistry-first” platform. Colorado-based Cime ...

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...

The new center will design novel drug-like molecules using generative AI and optimize existing compounds to enhance their ...

Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ...

IRBM is a contract research organization (CRO) focused on early-stage drug discovery. With a track record of delivering ...

The Icahn School of Medicine at Mount Sinai has launched the AI Small Molecule Drug Discovery Center, a bold endeavor that harnesses artificial intelligence (AI) to revolutionize drug development.

This eBook explores the latest advancements in drug discovery, from AI-driven precision medicine to the promise and risks of new weight loss drugs.

M ass firings hit U.S. health agencies over the past week, but disruptions to the nation’s medical research system have been ...